ReviewInternational journal of preventive medicine2026
Dietary Inflammatory Index and Coronary Artery Disease Risk and Mortality: A Nonlinear Dose-Response Systematic Review and Meta-Analysis.
Review in International journal of preventive medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: This systematic review and meta-analysis study aims to investigate the association between dietary inflammatory index (DII) and coronary artery disease (CAD) risk and mortality. Methods: A comprehensive search in PubMed, Web of Science, Embase, and Scopus was implemented for relevant observational studies investigating the relation between DII and risk of CAD and CAD mortality published up to May 2024. Articles that reported the relative risk, odd ratio (OR), or hazard ratio for the highest score of DII versus the lowest score of DII were retrieved. For quantitative analyses, categorical analysis, linear and nonlinear analyses, and subgroup analysis are performed. Results: Finally, 18 studies [CAD (n = 13) and CAD mortality (n = 5)] were included. Individuals with the highest score of DII versus the lowest ones have 38% (1.38; 95% CI: 1.22 to 1.56) and 40% (1.40; 95% CI: 1.13 to 1.75) more risk to CAD and CAD mortality, respectively. The linear analysis declared that the summary OR for CAD is 1.16 (95% CI: 1.08 to 1.24) and for CAD mortality 1.09 (95% CI: 1.03 to 1.14) per each 1-point increase in DII. There was also evidence of nonlinear relationship between the DII and CAD as the relation became even more significant when the DII were more than 2 points ( Conclusions: However, due to the large heterogeneity and some aforementioned limitations, more high-quality prospective studies can validate our results.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.